No definition available.
Drug-induced headache, not elsewhere classified
DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
196 |
4. Check minimum number of eventsNone |
196 |
5. Include endpointsNone |
196 |
6. Filter based on genotype QC (FinnGen only) |
196 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Drug-induced headache, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other headache syndromes
- Episodal and paroxysmal disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1129 | 777 | 342 |
| Only index persons | 1067 | 749 | 318 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 46.97 | 46.58 | 48.11 |
| Only index persons | 46.83 | 46.39 | 47.85 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 196 | 155 | 41 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.02 |
| Median age at first event (years) | 48.48 | 46.97 | 54.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 183
- Matched controls
- 1827
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G44.4
ICD-10 Finland
Drug-induced headache, not elsewhere classified
+∞
264.8
183
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
21.0
56.8
91
82
N03AX11
ATC
topiramate; oral
29.1
43.9
60
30
G43.3
ICD-10 Finland
Complicated migraine
42.1
42.1
52
17
R51.80
ICD-10 Finland
Headache
10.7
42.1
98
178
G44.2
ICD-10 Finland
Tension-type headache
10.0
37.8
89
158
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
8.5
35.7
97
214
G43.9
ICD-10 Finland
Migraine, unspecified
12.4
34.8
68
83
N02CC07
ATC
frovatriptan; oral
14.6
30.7
54
51
3007
Kela drug reimbursment
Erenumab and fremanezumab
41.7
30.1
37
11
N02CD01
ATC
erenumab; parenteral
55.0
27.5
32
7
C09CA06
ATC
candesartan; oral
6.4
27.4
91
245
N06CA01
ATC
amitriptyline and psycholeptics; systemic
8.2
26.5
66
117
N02CC04
ATC
rizatriptan; oral
10.2
26.0
55
74
N03AG01
ATC
valproic acid; systemic, rectal
11.8
25.4
49
55
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
9.5
24.6
54
77
G43
ICD-10 Finland
Migraine
12.2
24.4
46
49
N02CC05
ATC
almotriptan; oral
13.0
23.7
43
42
N02CC06
ATC
eletriptan; oral
11.7
21.5
41
44
N02CC03
ATC
zolmitriptan; nasal, oral
9.1
21.2
47
67
N02CD03
ATC
fremanezumab; systemic
47.9
21.1
25
6
N02CC02
ATC
naratriptan; oral
24.3
20.7
29
14
N06AA09
ATC
amitriptyline; systemic
7.4
20.5
53
96
N03AX12
ATC
gabapentin; oral
6.1
19.3
59
133
M03AX01
ATC
botulinum toxin; parenteral
34.2
18.9
24
8
N03AX16
ATC
pregabalin; oral
4.6
17.8
74
233
N01
ICPC
Headache
6.0
17.4
53
117
G43.8
ICD-10 Finland
Other migraine
18.7
17.1
26
16
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
16.6
73
239
N06AX21
ATC
duloxetine; oral
5.8
16.3
50
111
C07AA05
ATC
propranolol; systemic
4.2
16.0
76
266
N89
ICPC
Migraine
9.7
15.6
32
39
C07AB02
ATC
metoprolol; systemic
4.7
14.8
56
156
N02AX02
ATC
tramadol; systemic, rectal
3.5
14.5
103
491
M01AG02
ATC
tolfenamic acid; oral, rectal
4.0
14.4
68
233
A02BC03
ATC
lansoprazole; oral
3.7
14.2
82
331
G44.0
ICD-10 Finland
Cluster headache syndrome
16.8
13.5
21
14
N05BA01
ATC
diazepam; systemic, rectal
4.9
12.8
45
114
C07AB07
ATC
bisoprolol; oral
3.2
12.8
98
482
N06AX16
ATC
venlafaxine; oral
4.4
12.6
51
149
M03BX02
ATC
tizanidine; oral
3.5
12.3
144
944
A02BC02
ATC
pantoprazole; systemic
3.3
12.2
138
877
C08DA01
ATC
verapamil; systemic
9.6
11.4
23
27
M79.1
ICD-10 Finland
Myalgia
4.2
11.3
46
135
A02BA02
ATC
ranitidine; systemic
3.6
10.8
54
189
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
25.1
10.4
14
6
A02BC05
ATC
esomeprazole; systemic
2.8
10.3
98
528
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
10.1
94
499
AA1AD
NOMESCO Finland
CT of head and brain
3.3
9.8
56
214
R53
ICD-10 Finland
Malaise and fatigue
3.3
9.8
57
222
Z01.8
ICD-10 Finland
Other specified special examinations
3.2
9.6
61
250
M01AE02
ATC
naproxen; oral, rectal
2.8
9.5
130
854
N06AA10
ATC
nortriptyline; systemic
11.6
9.5
17
16
M03BC51
ATC
orphenadrine, combinations; systemic
2.8
9.4
75
360
N02CX04
ATC
NA
12.4
9.3
16
14
N06AX11
ATC
mirtazapine; oral
2.7
8.9
80
409
M03BC01
ATC
orphenadrine (citrate); systemic
2.9
8.9
64
286
H02AB06
ATC
prednisolone; systemic
2.6
8.9
105
624
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
8.8
41
134
R51
ICD-10 Finland
Headache
5.2
8.8
27
59
G43.2
ICD-10 Finland
Status migrainosus
29.1
8.6
11
*
N05AH04
ATC
quetiapine; oral
3.2
8.5
49
186
H02AB07
ATC
prednisone; oral
3.3
8.4
46
170
N02BE01
ATC
paracetamol; systemic, rectal
3.8
8.2
167
1339
M01AE03
ATC
ketoprofen; systemic, rectal
2.5
7.9
83
454
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.8
7.9
34
104
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
7.8
29
77
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
7.8
64
303
N02CD02
ATC
galcanezumab; parenteral
47.0
7.8
9
*
N06AB04
ATC
citalopram; systemic
2.8
7.6
57
256
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
7.6
101
619
N03AX09
ATC
lamotrigine; oral
5.4
7.6
22
45
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
7.4
60
281
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.4
7.4
26
66
R07.4
ICD-10 Finland
Chest pain, unspecified
2.8
7.3
55
246
Z76.0
ICD-10 Finland
Issue of repeat prescription
3.1
7.2
43
167
N03AE01
ATC
clonazepam; systemic
4.7
7.0
23
54
N05BA04
ATC
oxazepam; oral
2.5
6.9
62
307
M01AB05
ATC
diclofenac; systemic, rectal
2.4
6.9
135
985
K07.61
ICD-10 Finland
Cracking jaw joint
12.9
6.7
11
9
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.1
6.6
37
137
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
6.6
44
183
N06AX12
ATC
bupropion; oral
4.3
6.5
23
59
N02CA01
ATC
dihydroergotamine; nasal, systemic
18.8
6.3
9
5
R42
ICD-10 Finland
Dizziness and giddiness
2.6
6.3
48
217
P01AB01
ATC
metronidazole; oral, rectal
2.2
6.3
87
528
G44.3
ICD-10 Finland
Chronic post-traumatic headache
+∞
6.3
6
*
SPAT1050
SPAT
Extensive neurological examination
9.1
6.2
12
14
N06AB03
ATC
fluoxetine; oral
3.0
6.1
37
143
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
118
686
2.81
11.22
8.5
5.7
mmol/l
1.2
1.2
0.33
106
571
(3044290) Cell count panel - Cerebral spinal fluid
17
28
6.55
10.10
1.6
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
358
2.71
9.83
2.6
1.9
mg/l
2.9
2.9
0.02
62
308
(3013707) Erythrocyte sedimentation rate by Westergren method
166
1213
3.41
9.42
4.4
3.9
mm/h
9.9
10.2
0.11
160
1123
(3019198) Lymphocytes [#/volume] in Blood
129
830
2.62
9.33
9.6
5.5
e9/l
1.8
2.0
0.51
117
754
(3024561) Albumin [Mass/volume] in Serum or Plasma
105
615
2.52
9.25
4.2
4.3
g/l
37.2
36.3
0.94
98
576
(3001604) Monocytes [#/volume] in Blood
126
806
2.58
9.15
9.6
5.5
e9/l
0.5
0.5
0.09
115
722
(3006315) Basophils [#/volume] in Blood
126
808
2.57
9.07
9.6
5.5
e9/l
0.0
0.0
1.20
115
724
(3001122) Ferritin [Mass/volume] in Serum or Plasma
124
791
2.55
9.00
4.3
2.8
ug/l
71.5
83.3
0.78
118
736
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
565
2.47
8.82
2.2
1.8
pmol/l
95.0
100.3
0.55
49
291
(3013115) Eosinophils [#/volume] in Blood
128
839
2.52
8.61
9.6
5.9
e9/l
0.2
0.2
0.15
117
766
(3013650) Neutrophils [#/volume] in Blood by Automated count
138
943
2.57
8.38
10.9
9.0
e9/l
3.8
4.0
1.02
125
833
(3037467) Urinalysis macro (dipstick) panel - Urine
154
1116
2.77
8.16
5.5
4.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
117
748
2.40
8.15
9.3
5.4
%
2.9
2.8
0.19
111
702
(3019069) Monocytes/100 leukocytes in Blood
117
751
2.38
8.03
9.5
5.7
%
8.2
8.0
0.43
112
713
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
71
369
2.45
7.84
1.9
1.7
mg/l
0.9
0.8
0.24
49
285
(3022096) Basophils/100 leukocytes in Blood
113
720
2.34
7.81
9.5
5.4
%
0.7
0.7
0.68
108
675
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
103
634
2.32
7.69
6.4
4.9
mmol/l
1.2
1.2
0.44
97
571
(3037522) Nuclear Ab [Titer] in Serum
53
243
2.62
7.60
1.4
1.4
titre
756.4
421.8
1.05
11
57
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
79
437
2.35
7.54
3.5
2.0
u/l
106.3
327.2
0.85
74
418
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
168
1294
3.09
7.54
5.8
4.1
pmol/l
14.3
14.5
0.68
160
1202
(3007164) IgA [Mass/volume] in Serum or Plasma
71
375
2.40
7.52
1.6
1.4
g/l
2.0
2.3
0.49
42
237
(3035637) Corticotropin [Mass/volume] in Plasma
12
19
6.66
7.33
1.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
223
2.53
6.62
3.8
2.4
e6/l
5.8
3.1
0.66
25
118
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
89
552
2.12
6.14
3.1
3.4
ng/l
14.6
39.9
1.62
38
325
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
40
4.27
6.02
1.3
1.1
e6/l
3.3
3.0
—
10
32
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
52
261
2.35
6.02
2.6
2.7
mmol/l
2.4
2.4
0.71
45
227
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
414
2.17
6.01
1.5
1.2
u/ml
0.5
1.5
1.75
15
125
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
22
71
3.36
5.82
1.4
2.6
u/l
35.6
41.6
0.80
22
65
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
85
528
2.08
5.75
4.1
2.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
182
1534
3.61
5.67
6.9
4.8
mu/l
1.7
2.6
0.58
174
1423
(40768797) Stomach Pathology biopsy report
43
204
2.42
5.62
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
171
2.52
5.55
1.7
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
76
459
2.07
5.50
3.6
2.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
48
242
2.30
5.46
3.4
2.3
e6/l
1.6
1.0
0.64
26
137
(3012544) pH of Venous blood
28
110
2.80
5.33
4.9
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
61
343
2.13
5.30
2.4
2.9
ng/l
864.0
733.2
0.13
48
287
(3048689) Calprotectin [Mass/mass] in Stool
44
218
2.31
5.19
2.6
2.5
ug/g
117.5
111.0
0.07
31
170
(3018095) Leukocytes [#/volume] in Urine
85
550
1.96
4.97
5.0
3.1
e6/l
28.2
54.1
1.03
56
383
(3000991) Gas panel - Venous blood
25
96
2.84
4.95
13.1
4.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
154
1227
2.19
4.89
9.1
6.8
u/l
74.3
76.7
0.43
146
1143
(3019309) Folate [Moles/volume] in Red Blood Cells
46
240
2.20
4.78
1.6
1.6
nmol/l
1153.7
1205.4
0.13
36
179
(3003327) Ova and parasites identified in Stool by Light microscopy
18
58
3.32
4.77
1.4
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
59
340
2.05
4.74
4.7
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
66
401
1.97
4.56
7.2
6.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
68
420
1.95
4.46
3.5
2.6
e6/l
0.0
0.4
3.40
46
310
(3024354) Oxygen [Partial pressure] in Venous blood
23
90
2.76
4.40
4.7
2.5
kpa
4.8
4.7
0.07
23
90
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
48
263
2.09
4.38
5.6
3.2
ng/l
58.3
109.4
0.46
27
169
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
9
9.20
4.32
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
9
9.20
4.32
2.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
6
12.03
4.31
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
13
7.20
4.21
1.9
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
151
2.34
4.19
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
68
428
1.90
4.18
2.7
3.7
ph
7.4
7.4
—
7
82
(3002582) Erythrocytes [#/volume] in Urine
72
467
1.86
4.00
4.0
2.7
e6/l
13.7
178.7
0.62
50
352
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
335
1.94
3.98
5.1
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
176
1526
2.50
3.87
15.9
10.5
ml/min/173m2
86.3
86.7
0.08
158
1227
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
55
330
1.93
3.86
1.3
1.3
iu/ml
13.2
32.1
2.22
15
110
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
103
2.52
3.85
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
62
2.91
3.69
1.9
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
52
3.04
3.55
1.9
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
199
2.06
3.51
2.0
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
186
1672
3.20
3.50
20.9
11.7
mg/l
17.5
19.6
0.55
155
1258
(3015377) Calcium [Moles/volume] in Serum or Plasma
75
510
1.76
3.48
2.3
3.0
mmol/l
2.3
2.3
1.11
64
457
(4094501)
13
42
3.24
3.44
1.1
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
114
878
1.71
3.34
6.6
3.8
mmol/l
6.2
6.5
0.83
109
802
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
97
2.43
3.34
1.6
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
38
211
1.99
3.31
2.1
1.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
7
8.79
3.28
1.2
1.1
%
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
24
113
2.28
3.16
1.3
1.3
u/ml
108.3
329.6
0.50
24
99
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
147
1225
1.80
3.16
4.0
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
48
293
1.85
3.15
3.4
2.3
mosm/kgh2o
507.8
553.6
0.61
39
248
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
285
1.85
3.15
1.5
1.7
pmol/l
454.3
434.9
0.24
40
249
(3021589) Normoblasts [#/volume] in Blood
95
708
1.66
3.06
12.9
8.4
e9/l
0.0
0.0
0.63
75
594
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
387
1.75
3.05
1.8
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
5
10.21
2.99
1.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
63
423
1.72
2.99
3.7
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
61
408
1.72
2.93
5.8
4.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
72
504
1.68
2.92
9.4
5.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
32
175
1.99
2.90
1.5
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
53
2.77
2.86
1.6
1.7
—
—
—
0
0
(4062490)
8
18
4.59
2.82
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
315
1.74
2.69
1.3
1.3
u/ml
1.2
7.7
2.28
23
140
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
15
4.80
2.62
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
188
1751
2.80
2.60
13.5
9.2
u/l
25.5
24.8
0.17
188
1697
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
7
7.29
2.56
2.4
7.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
7
7.29
2.56
2.0
1.9
%
103.8
115.1
—
5
7
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
16
4.49
2.50
1.3
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
16
4.49
2.50
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
16
4.49
2.50
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
173
1552
1.98
2.48
4.4
4.0
mmol/l
5.6
5.8
2.53
163
1443
(3044889) 12 lead EKG panel
128
1060
1.60
2.48
3.9
3.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
165
1460
1.82
2.45
25.1
15.0
g/l
331.8
332.1
0.18
165
1455
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
58
2.52
2.43
7.1
3.0
%
53.9
49.7
0.26
14
58
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
58
2.52
2.43
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
101
795
1.56
2.42
5.1
3.4
estimate
0.0
0.0
0.00
20
152
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
11
40
2.85
2.41
1.4
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
100
787
1.55
2.39
5.0
3.4
estimate
0.0
0.0
0.00
19
157
(3021601) Nitrite [Presence] in Urine by Test strip
100
787
1.55
2.39
7.3
4.6
estimate
0.0
0.0
0.00
21
158
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
171
1533
1.91
2.39
3.8
3.5
mmol/l
1.3
1.3
0.70
161
1419
(3044927) Protein electrophoresis panel - Urine
5
8
6.38
2.38
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
17
4.23
2.38
1.3
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
59
2.48
2.35
1.4
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
35
2.96
2.34
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
143
1.94
2.33
1.2
1.2
iu/ml
36.7
147.0
—
8
57
(3023410) Appearance of Cerebral spinal fluid
7
18
3.99
2.27
1.1
1.2
—
—
—
0
0
(3013512) EKG study
58
407
1.60
2.26
3.6
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
179
1636
2.09
2.25
4.9
4.3
mmol/l
2.9
2.8
0.25
171
1521
(40768804) Tissue Pathology biopsy report
87
676
1.52
2.14
2.1
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
25
3.29
2.12
1.9
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
56
2.42
2.09
5.1
3.2
—
—
—
0
0
(3020891) Body temperature
12
50
2.49
2.07
2.3
4.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
136
1166
1.54
2.06
3.5
2.8
u/l
35.7
40.6
0.59
131
1104
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
175
1601
1.87
1.99
4.3
3.9
mmol/l
1.5
1.5
0.73
165
1490
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
21
3.42
1.98
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
58
2.33
1.95
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
39
2.65
1.95
1.1
1.3
—
—
—
0
0
(4027681)
5
11
4.63
1.95
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
11
4.63
1.95
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
16
79
2.12
1.91
4.5
2.9
—
7.4
—
0
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
22
3.26
1.90
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
467
1.51
1.90
4.9
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
59
2.29
1.88
1.6
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
28
2.93
1.88
1.5
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
12
4.24
1.83
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
60
2.25
1.82
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
161
1451
1.61
1.79
4.8
4.9
mmol/mol
37.1
38.9
2.23
153
1369
(3052851) Hemolysis interference index of Serum or Plasma
10
41
2.52
1.78
1.9
2.4
—
—
—
0
0
(4010399)
18
96
1.96
1.77
1.3
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
19
104
1.92
1.74
2.1
2.2
g/l
0.2
0.2
0.74
14
99
(3037121) Protein [Mass/volume] in Urine
11
48
2.37
1.74
1.0
3.8
g/l
0.4
0.2
—
6
17
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
11
48
2.37
1.74
5.4
3.5
mmol/l
24.6
25.0
0.33
11
48
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
13
3.92
1.72
8.0
8.4
mmol/l
0.5
0.7
—
5
13
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29
183
1.69
1.69
2.4
2.3
umol/l
4.0
6.6
1.65
21
159
(3017143) Hepatitis C virus Ab [Presence] in Serum
33
216
1.63
1.68
1.3
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
25
2.86
1.66
1.6
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
185
1741
2.12
1.65
16.7
11.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
14
3.64
1.62
1.2
1.3
—
72.2
—
0
5
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
32
2.56
1.61
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
174
1611
1.71
1.59
4.5
3.9
mmol/l
4.8
4.8
0.15
166
1508
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
123
1.79
1.58
1.1
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
51
375
1.49
1.57
2.1
2.5
umol/l
6431.2
5744.0
0.04
44
333
(3028626) Oxygen [Partial pressure] in Capillary blood
8
33
2.48
1.55
2.3
2.2
kpa
8.9
8.7
—
8
28
(3011288) Drugs identified in Urine by Screen method
11
51
2.23
1.53
4.3
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
15
3.39
1.53
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
386
1.47
1.53
1.7
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
21
2.91
1.51
1.2
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
21
2.91
1.51
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
239
1.57
1.51
2.4
1.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
59
2.10
1.47
3.4
2.6
%
1.7
1.2
0.48
12
59
(4306422)
6
22
2.78
1.44
1.3
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
74
1.96
1.43
5.2
3.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
53
2.14
1.41
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
90
1.85
1.37
3.2
1.9
u/l
53.0
4196.4
—
6
26
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
17
2.99
1.36
1.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
55
423
1.42
1.33
5.1
3.7
estimate
0.0
0.0
0.00
20
155
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
629
1.37
1.31
5.1
3.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
62
2.00
1.31
2.4
2.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
18
2.82
1.29
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
18
2.82
1.29
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
18
2.82
1.29
1.6
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
18
2.82
1.29
1.6
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
67
538
1.37
1.26
5.3
6.3
inr
1.1
1.1
0.19
17
179
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
78
1.86
1.24
2.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
49
2.10
1.24
1.3
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
174
1.57
1.23
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
37
2.21
1.23
4.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
19
2.67
1.22
1.6
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
19
2.67
1.22
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
19
2.67
1.22
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
26
2.35
1.19
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
166
1545
1.49
1.18
23.6
12.1
%
38.4
40.4
1.76
134
1217
(3000963) Hemoglobin [Mass/volume] in Blood
191
1848
2.31
1.17
29.8
17.6
g/l
133.6
134.5
0.46
191
1821
(3035941) MCH [Entitic mass]
191
1847
2.34
1.17
29.5
17.4
pg
30.0
30.1
0.36
191
1822
(3024731) MCV [Entitic volume]
191
1846
2.36
1.16
29.5
17.4
fl
90.3
90.6
0.34
191
1821
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
73
1.84
1.14
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
145
1.58
1.12
2.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
66
1.87
1.11
3.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
15
89
1.74
1.11
2.0
2.7
e9/l
68.9
75.2
—
9
68
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
21
2.42
1.09
1.2
1.1
—
—
—
0
0
(4034850)
10
52
1.97
1.08
7.3
7.0
—
—
—
0
0
(3019225) pH of Specimen
20
130
1.60
1.07
6.1
4.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
33
2.16
1.06
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
33
2.16
1.06
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
18
115
1.62
1.04
14.3
5.7
%
96.6
95.6
0.69
18
108
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
42
322
1.39
1.03
1.5
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
48
1.92
1.02
1.4
2.3
g/l
1.0
1.3
—
9
41
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
35
2.04
1.01
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
270
1.41
1.00
2.5
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
49
1.88
1.00
2.9
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
77
1.74
0.98
3.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
41
318
1.37
0.94
2.6
2.3
e6/l
3.6
8.9
1.27
30
279
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
27
2.26
0.94
1.5
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
27
2.26
0.94
1.3
2.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
27
2.26
0.94
5.7
2.8
mmol/l
1.0
1.3
—
6
27
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
102
1.62
0.94
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
45
1.81
0.85
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
31
1.96
0.85
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
81
1.65
0.83
3.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
26
191
1.42
0.82
4.5
3.9
%
21.8
21.3
0.08
14
77
(3045424) Erythrocytes [Presence] in Urine
6
32
1.90
0.82
1.2
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
16
106
1.55
0.82
15.9
6.0
g/l
123.6
122.3
0.11
16
101
(3025941) Bacteria identified in Stool by Culture
16
106
1.55
0.82
1.5
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
344
1.32
0.81
4.9
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
174
1.43
0.81
7.6
6.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
82
1.63
0.80
3.6
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
82
1.63
0.80
3.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
43
345
1.32
0.80
6.3
3.8
kg/l
1.0
1.0
—
6
41
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
24
0.00
0.79
0.0
3.6
—
59.2
—
0
24
(21494755) Public health laboratory ask at order entry panel
16
231
0.67
0.79
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
47
383
1.30
0.78
2.7
3.7
mg/mmol
10.1
7.7
0.11
28
238
(3027801) Oxygen [Partial pressure] in Arterial blood
19
133
1.47
0.77
13.6
5.2
kpa
11.3
12.6
1.00
19
126
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
19
133
1.47
0.77
13.8
5.2
kpa
5.1
5.1
0.08
19
126
(1761482) Bacteria [#/volume] in Urine by Culture
6
34
1.79
0.77
6.3
4.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
38
1.87
0.74
1.4
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
60
1.70
0.73
1.6
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
39
1.82
0.73
1.7
4.3
mmol/l
3.9
4.0
—
7
34
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
25
2.03
0.73
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
40
1.78
0.72
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
26
1.95
0.71
2.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
26
1.95
0.71
2.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
110
1.49
0.71
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
162
1.40
0.70
1.5
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
61
1.67
0.70
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
145
1.42
0.69
2.8
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
27
1.87
0.69
6.6
2.8
mmol/l
5.9
7.0
—
5
27
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
31
388
0.76
0.67
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
62
1.65
0.66
1.8
1.3
—
—
—
0
0
(1002224) Polysomnography panel
13
87
1.53
0.65
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
49
1.66
0.63
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
30
1.68
0.62
3.8
3.8
e9/l
4.7
5.2
—
5
30
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
30
1.68
0.62
3.8
4.5
%
62.6
61.0
—
5
30
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
53
1.53
0.59
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
115
1.43
0.58
5.1
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
133
1.39
0.57
1.5
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
55
475
1.22
0.57
3.9
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
66
1.54
0.53
1.5
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
83
1.47
0.53
3.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
40
1.52
0.52
1.3
2.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
75
1.49
0.52
1.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
42
361
1.21
0.46
2.0
3.0
mg/l
14.0
51.9
2.35
24
226
(3019832) Treponema pallidum Ab [Presence] in Serum
28
230
1.25
0.46
1.5
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
50
1.41
0.45
3.9
4.8
%
1.7
1.5
—
7
45
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
176
1.28
0.44
3.6
4.2
%
35.2
32.6
0.39
16
118
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
122
1.34
0.44
3.4
2.9
ml/min/173m2
74.6
73.7
—
10
50
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
139
0.70
0.43
2.0
3.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
31
1.63
0.43
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
57
1.42
0.42
1.1
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
33
1.53
0.41
2.8
2.0
mmol/l
25.6
24.5
—
5
26
(40768795) Lymph node Pathology biopsy report
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
36
1.40
0.38
3.2
3.0
mg/l
1.0
1.5
—
5
31
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
125
1.30
0.38
1.5
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
57
1.24
0.29
31.3
6.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
94
1.29
0.29
6.4
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
67
1.20
0.26
4.8
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
73
1.24
0.26
3.8
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
142
1.22
0.25
1.6
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
10
78
1.30
0.24
1.4
1.5
mu/l
539.3
270.6
—
10
72
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
12.8
—
0
11
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
78
743
1.08
0.18
5.9
4.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
68
1.18
0.17
1.1
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
68
1.18
0.17
1.1
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
68
1.18
0.17
1.1
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
68
1.18
0.17
1.3
1.6
—
—
—
0
0
(3000492) Spirometry study
17
149
1.15
0.16
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
95
0.84
0.14
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
63
657
0.94
0.12
2.4
2.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
45
1.11
0.10
1.8
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
77
1.04
0.07
23.4
3.4
mmol/l
24.5
24.6
—
8
77
(3002256) Pathology report gross observation
19
202
0.93
0.05
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
199
1.06
0.05
2.1
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
48
467
1.04
0.04
1.4
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
140
0.92
0.04
3.9
3.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
191
1.05
0.03
1.6
1.7
—
—
—
0
0
(4035726)
12
128
0.93
0.02
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
215
1.03
0.00
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.7
—
11.1
—
0
7
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.4
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
89
0.89
0.00
1.5
1.5
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
61
0.98
0.00
1.3
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
15.5
—
0
6
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
61
0.98
0.00
1.3
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
204.6
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
59
0.84
0.00
2.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
82
0.97
0.00
2.1
4.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
64
0.94
0.00
1.5
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
60
1.00
0.00
1.7
1.9
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
130
1.00
0.00
1.6
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
94
0.96
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED | 1.32 [1.0, 1.74] | 0.046 |
| Birth year | 0.995 [0.99, 1.0] | 0.258 |
During the follow-up period (1.1.1998 — 31.12.2019), 76 out of 665 females with DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED | 1.614 [1.08, 2.4] | 0.019 |
| Birth year | 0.989 [0.98, 1.0] | 0.076 |
During the follow-up period (1.1.1998 — 31.12.2019), 56 out of 305 males with DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.147% | 0.348% |
| 5 | 0.718% | 1.909% |
| 10 | 1.867% | 4.967% |
| 15 | 3.603% | 9.259% |
| 20 | 6.513% | 15.684% |
Relationships between endpoints
↥Index endpoint: DRUGADVERS_HEADA_NOT_ELSEW_CLASSIFIED – Drug-induced headache, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data